Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank30
3Y CAGR-30.0%
5Y CAGR-7.2%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-30.0%/yr
Quarterly compound
5Y CAGR
-7.2%/yr
Recent deceleration
Percentile
P30
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
5 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.70% |
| Q3 2025 | 6.19% |
| Q2 2025 | 7.00% |
| Q1 2025 | 8.90% |
| Q4 2024 | 10.01% |
| Q3 2024 | 10.68% |
| Q2 2024 | 4.44% |
| Q1 2024 | 13.38% |
| Q4 2023 | -0.41% |
| Q3 2023 | -0.61% |
| Q2 2023 | 9.07% |
| Q1 2023 | 9.51% |
| Q4 2022 | 16.66% |
| Q3 2022 | 39.08% |
| Q2 2022 | 14.63% |
| Q1 2022 | 14.31% |
| Q4 2021 | 20.95% |
| Q3 2021 | 18.50% |
| Q2 2021 | 17.21% |
| Q1 2021 | 11.01% |
| Q4 2020 | 8.29% |
| Q3 2020 | 301.32% |
| Q2 2020 | 6.21% |
| Q1 2020 | -298.64% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |